DE60336588D1 - Verbesserte anthraximpfstoffe und abgabeverfahren - Google Patents
Verbesserte anthraximpfstoffe und abgabeverfahrenInfo
- Publication number
- DE60336588D1 DE60336588D1 DE60336588T DE60336588T DE60336588D1 DE 60336588 D1 DE60336588 D1 DE 60336588D1 DE 60336588 T DE60336588 T DE 60336588T DE 60336588 T DE60336588 T DE 60336588T DE 60336588 D1 DE60336588 D1 DE 60336588D1
- Authority
- DE
- Germany
- Prior art keywords
- delivery
- anthraximp
- improved
- anthrax
- vaccines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000193738 Bacillus anthracis Species 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 229960005447 anthrax vaccines Drugs 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44699503P | 2003-02-13 | 2003-02-13 | |
US48646003P | 2003-07-14 | 2003-07-14 | |
PCT/US2003/025158 WO2004073735A1 (en) | 2003-02-13 | 2003-08-13 | Improved anthrax vaccines and delivery methods |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60336588D1 true DE60336588D1 (de) | 2011-05-12 |
Family
ID=32912248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60336588T Expired - Lifetime DE60336588D1 (de) | 2003-02-13 | 2003-08-13 | Verbesserte anthraximpfstoffe und abgabeverfahren |
Country Status (7)
Country | Link |
---|---|
US (1) | US20070154494A1 (de) |
EP (1) | EP1592443B1 (de) |
JP (1) | JP2006517913A (de) |
AT (1) | ATE503491T1 (de) |
AU (1) | AU2003255275A1 (de) |
DE (1) | DE60336588D1 (de) |
WO (1) | WO2004073735A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1735338B1 (de) | 2004-02-11 | 2013-04-24 | Ligocyte Pharmaceuticals, Inc. | Anthrax-antigene und anwendungsverfahren |
GB0607462D0 (en) * | 2006-04-13 | 2006-05-24 | Avecia Ltd | Assay |
US20080226729A1 (en) * | 2006-09-08 | 2008-09-18 | Becton, Dickinson And Company | Stable powder formulations of alum-adsorbed vaccines |
EP1972347A1 (de) * | 2007-03-19 | 2008-09-24 | Becton, Dickinson and Company, Wagner, Jaconda | Stabile Impfstoffpulverformulierungen |
AU2008263970B2 (en) * | 2007-06-14 | 2014-01-30 | Crucell Switzerland Ag | Intradermal influenza vaccine |
CA2716399C (en) | 2008-03-05 | 2020-07-21 | Pierre Chouvenc | Process for stabilizing an adjuvant containing vaccine composition |
WO2010038076A1 (en) | 2008-10-02 | 2010-04-08 | Pharmathene Uk Limited | Anthrax vaccine formulation and uses thereof |
US20100183675A1 (en) * | 2009-01-22 | 2010-07-22 | Allan Watkinson | Stable vaccine compositions and methods of use |
JP2012515752A (ja) * | 2009-01-22 | 2012-07-12 | ファーマシーネ,インコーポレイテッド | 安定なワクチン組成物とその使用方法 |
GB201007207D0 (en) * | 2010-04-29 | 2010-06-16 | Univ Cork | Method |
WO2013139384A1 (en) * | 2012-03-21 | 2013-09-26 | Dorkoosh, Farid Abedin | Freezing of aerosolized solutions (fas): a system for continuous particle production |
CN110227152A (zh) * | 2012-04-23 | 2019-09-13 | 巴拉特生物技术国际有限公司 | 轮状病毒疫苗组合物及其制备方法 |
JP6028063B2 (ja) * | 2015-04-30 | 2016-11-16 | ナノメド ディヴァイシーズ, インコーポレイテッド | アプリケータに統合可能な内蔵非言語的指示デバイス |
EP3669929A4 (de) * | 2017-08-17 | 2021-05-12 | Cosmed Pharmaceutical Co., Ltd. | Mikronadelfeld für lippen |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7012832A (de) * | 1970-08-29 | 1972-03-02 | ||
US5840312A (en) * | 1991-05-02 | 1998-11-24 | Institut Pasteur | Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein |
JP2930526B2 (ja) * | 1994-05-31 | 1999-08-03 | 株式会社キートロン | インジェクター型アトマイザー |
US6316006B1 (en) * | 1994-11-23 | 2001-11-13 | The United States Of America As Represented By The Secretary Of The Army | Asporogenic B anthracis expression system |
US6348450B1 (en) * | 1997-08-13 | 2002-02-19 | The Uab Research Foundation | Noninvasive genetic immunization, expression products therefrom and uses thereof |
US6284282B1 (en) * | 1998-04-29 | 2001-09-04 | Genentech, Inc. | Method of spray freeze drying proteins for pharmaceutical administration |
US6770479B1 (en) * | 1998-07-10 | 2004-08-03 | The United States Of America As Represented By The Secretary Of The Army | Anthrax vaccine |
US6329156B1 (en) * | 1999-03-22 | 2001-12-11 | The Regents Of The University Of California | Method for screening inhibitors of the toxicity of Bacillus anthracis |
FR2798291B1 (fr) * | 1999-09-10 | 2005-01-14 | Pasteur Institut | Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis |
US6835184B1 (en) * | 1999-09-24 | 2004-12-28 | Becton, Dickinson And Company | Method and device for abrading skin |
US6595947B1 (en) * | 2000-05-22 | 2003-07-22 | Becton, Dickinson And Company | Topical delivery of vaccines |
WO2002100340A2 (en) * | 2001-06-08 | 2002-12-19 | Avant Immunotherapeutics, Inc. | Improved vaccination against anthrax |
BR0210628A (pt) * | 2001-06-29 | 2004-08-10 | Becton Dickinson Co | Liberação intradérmica de vacinas e agentes terapêuticos genéticos via microcânula |
BR0214279A (pt) * | 2001-11-19 | 2005-12-20 | Becton Dickinson Co | Composições farmacêuticas em forma particulada |
-
2003
- 2003-08-13 WO PCT/US2003/025158 patent/WO2004073735A1/en active Application Filing
- 2003-08-13 EP EP03815990A patent/EP1592443B1/de not_active Expired - Lifetime
- 2003-08-13 JP JP2004568559A patent/JP2006517913A/ja active Pending
- 2003-08-13 DE DE60336588T patent/DE60336588D1/de not_active Expired - Lifetime
- 2003-08-13 AU AU2003255275A patent/AU2003255275A1/en not_active Abandoned
- 2003-08-13 AT AT03815990T patent/ATE503491T1/de not_active IP Right Cessation
- 2003-08-13 US US10/639,762 patent/US20070154494A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003255275A1 (en) | 2004-09-09 |
JP2006517913A (ja) | 2006-08-03 |
WO2004073735A1 (en) | 2004-09-02 |
US20070154494A1 (en) | 2007-07-05 |
ATE503491T1 (de) | 2011-04-15 |
EP1592443A4 (de) | 2007-02-21 |
EP1592443B1 (de) | 2011-03-30 |
EP1592443A1 (de) | 2005-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122681T1 (el) | Απο του στοματος σκευασματα αναλογων κυτιδινης και μεθοδοι χρησης αυτων | |
WO2007024941A3 (en) | Polyvalent vaccine | |
PH12014501836A1 (en) | Novel adjuvant compositions | |
DE60336588D1 (de) | Verbesserte anthraximpfstoffe und abgabeverfahren | |
MX2011006205A (es) | Proteinas f del vrs modificadas y metodos de uso de las mismas. | |
UA99659C2 (uk) | Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування | |
MX2007010996A (es) | Nuevas composiciones de liposomas. | |
TW200716646A (en) | (S)-N-methylnaltrexone | |
TW200740458A (en) | Vaccination against dengue virus infection | |
MX2012000035A (es) | Antigenos de virus de sincicio respiratorio recombinantes. | |
MY129263A (en) | Vaccine composition | |
MX2009004862A (es) | Estabilizacion de vacunas por liofilizacion. | |
GB0109297D0 (en) | Vaccine | |
GB2386072A (en) | Novel vaccine | |
WO2009009759A3 (en) | Yersinia pestis antigens, vaccine compositions, and related methods | |
MX349119B (es) | Vacuna de virus de dengue inactivado. | |
HK1097774A1 (en) | Stable pharmaceutical composition comprising linezolid from iv | |
CR9246A (es) | Formulaciones terapeuticas del factor de crecimiento de queratinocitos | |
WO2010053610A3 (en) | Stable anthrax vaccine formulations | |
CY1112575T1 (el) | Βελτιωμενα αδρανοποιημενα εμβολια fcv | |
DE69922804D1 (de) | Verwendung von polymeren der hyaluronsäure zur mukosalen freigabe von impfstoffen und adjuvantien | |
WO2007028985A3 (en) | Adjuvanted vaccine | |
DE602005021873D1 (de) | Neues impfstoffadjuvans und dessen herstellung und verwendung | |
EA200701201A1 (ru) | Новая фармацевтическая композиция для вакцин | |
DK1604683T3 (da) | Gangliogsid-baserede vaccinesammensætninger til subkutan administration |